Timing of Maximal Effect for Suppressive Therapy in Oral HSV-1
Suppressive Therapy Effectiveness Timeline
- Daily suppressive therapy reduces the frequency of herpes recurrences by ≥75% among patients with frequent recurrences (six or more per year) 1, 3
- The full preventive effect builds gradually over time, with most patients experiencing significant reduction in outbreaks within the first few weeks of consistent therapy 4
- Safety and efficacy have been documented among patients receiving daily therapy with acyclovir for as long as 6 years, and with valacyclovir and famciclovir for 1 year 2
Medication Options for Suppressive Therapy
- Acyclovir 400 mg orally twice a day is a recommended regimen 2
- Famciclovir 250 mg orally twice a day is a recommended regimen 2
- Valacyclovir 250 mg orally twice a day is a recommended regimen 2
- Valacyclovir 500 mg orally once a day is a recommended regimen, but appears less effective than other valacyclovir dosing regimens in patients who have very frequent recurrences (≥10 episodes per year) 2, 3
- Valacyclovir 1,000 mg orally once a day is a recommended regimen 2
Clinical Pearls and Pitfalls
- Suppressive treatment reduces but does not eliminate asymptomatic viral shedding 2, 5
- After 1 year of continuous suppressive therapy, discontinuation should be considered to assess the patient's rate of recurrent episodes, as recurrence frequency often decreases over time 2
- Patients should be advised that while suppressive therapy significantly reduces outbreak frequency, it does not completely eliminate the risk of viral transmission 5
- For patients with HIV, higher doses may be needed - valacyclovir suppressive therapy should be 500 mg twice daily rather than once daily 6
- Resistance to antiviral medications is rare in immunocompetent patients but should be suspected if lesions do not begin to resolve within 7-10 days of therapy 6